5/120
0.2 / 5 stars
All 120 Win/Lose results shown below
UNCY Roast Me summary
Unicycive Therapeutics, Inc. (UNCY). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseUNCY / S&P -28.72% / 15.20% |
LoseUNCY / S&P UNCY unavailable / 15.00% |
LoseUNCY / S&P UNCY unavailable / 50.40% |
| 2026-Q11/3 |
WinUNCY / S&P 14.04% / -4.33% |
LoseUNCY / S&P UNCY unavailable / 11.30% |
LoseUNCY / S&P UNCY unavailable / 27.70% |
| 2025-Q41/3 |
WinUNCY / S&P 32.34% / 2.65% |
LoseUNCY / S&P UNCY unavailable / 9.00% |
LoseUNCY / S&P UNCY unavailable / 13.40% |
| 2025-Q30/3 |
LoseUNCY / S&P -8.60% / 8.12% |
LoseUNCY / S&P UNCY unavailable / 4.61% |
LoseUNCY / S&P UNCY unavailable / 13.45% |
| 2025-Q20/3 |
LoseUNCY / S&P -17.04% / 10.94% |
LoseUNCY / S&P UNCY unavailable / 4.83% |
LoseUNCY / S&P UNCY unavailable / 10.63% |
| 2025-Q10/3 |
LoseUNCY / S&P -27.58% / -4.27% |
LoseUNCY / S&P UNCY unavailable / 4.98% |
LoseUNCY / S&P UNCY unavailable / 10.57% |
| 2024-Q41/3 |
WinUNCY / S&P 94.61% / 2.41% |
LoseUNCY / S&P UNCY unavailable / 5.25% |
LoseUNCY / S&P UNCY unavailable / 6.15% |
| 2024-Q30/3 |
LoseUNCY / S&P -18.56% / 5.89% |
LoseUNCY / S&P UNCY unavailable / 5.89% |
LoseUNCY / S&P UNCY unavailable / 6.11% |
| 2024-Q20/3 |
LoseUNCY / S&P -63.70% / 4.28% |
LoseUNCY / S&P UNCY unavailable / 5.38% |
LoseUNCY / S&P UNCY unavailable / 5.12% |
| 2024-Q11/3 |
WinUNCY / S&P 58.99% / 10.56% |
LoseUNCY / S&P UNCY unavailable / 5.71% |
LoseUNCY / S&P UNCY unavailable / 5.59% |
| 2023-Q40/3 |
LoseUNCY / S&P 0.93% / 11.69% |
LoseUNCY / S&P -29.02% / 6.81% |
LoseUNCY / S&P UNCY unavailable / 7.78% |
| 2023-Q30/3 |
LoseUNCY / S&P -32.81% / -3.27% |
LoseUNCY / S&P UNCY unavailable / 7.52% |
LoseUNCY / S&P UNCY unavailable / -5.03% |
| 2023-Q20/3 |
LoseUNCY / S&P -39.05% / 8.74% |
LoseUNCY / S&P UNCY unavailable / 9.50% |
LoseUNCY / S&P UNCY unavailable / -8.57% |
| 2023-Q11/3 |
WinUNCY / S&P 288.89% / 7.50% |
LoseUNCY / S&P UNCY unavailable / 10.77% |
LoseUNCY / S&P UNCY unavailable / -15.69% |
| 2022-Q40/3 |
LoseUNCY / S&P -8.47% / 7.56% |
LoseUNCY / S&P UNCY unavailable / 11.88% |
LoseUNCY / S&P UNCY unavailable / -17.99% |
| 2022-Q30/3 |
LoseUNCY / S&P -28.92% / -4.88% |
LoseUNCY / S&P UNCY unavailable / 13.47% |
LoseUNCY / S&P UNCY unavailable / -1.41% |
| 2022-Q20/3 |
LoseUNCY / S&P -35.66% / -16.10% |
LoseUNCY / S&P UNCY unavailable / 13.71% |
LoseUNCY / S&P UNCY unavailable / 11.04% |
| 2022-Q10/3 |
LoseUNCY / S&P -37.38% / -4.60% |
LoseUNCY / S&P UNCY unavailable / 15.97% |
LoseUNCY / S&P UNCY unavailable / 42.23% |
| 2021-Q40/3 |
LoseUNCY / S&P -27.21% / 11.03% |
LoseUNCY / S&P UNCY unavailable / 15.00% |
LoseUNCY / S&P UNCY unavailable / 96.40% |
| 2021-Q30/3 |
LoseUNCY / S&P UNCY unavailable / 0.58% |
LoseUNCY / S&P UNCY unavailable / 10.77% |
LoseUNCY / S&P UNCY unavailable / 69.42% |
| 2021-Q20/3 |
LoseUNCY / S&P UNCY unavailable / 8.55% |
LoseUNCY / S&P UNCY unavailable / 6.58% |
LoseUNCY / S&P UNCY unavailable / 51.81% |
| 2021-Q10/3 |
LoseUNCY / S&P UNCY unavailable / 6.17% |
LoseUNCY / S&P UNCY unavailable / -1.06% |
LoseUNCY / S&P UNCY unavailable / 7.39% |
| 2020-Q40/3 |
LoseUNCY / S&P UNCY unavailable / 12.15% |
LoseUNCY / S&P UNCY unavailable / -3.72% |
LoseUNCY / S&P UNCY unavailable / -33.42% |
| 2020-Q30/3 |
LoseUNCY / S&P UNCY unavailable / 8.93% |
LoseUNCY / S&P UNCY unavailable / -2.04% |
LoseUNCY / S&P UNCY unavailable / -27.10% |
| 2020-Q20/3 |
LoseUNCY / S&P UNCY unavailable / 20.54% |
LoseUNCY / S&P UNCY unavailable / -0.46% |
LoseUNCY / S&P UNCY unavailable / -27.11% |
| 2020-Q10/3 |
LoseUNCY / S&P UNCY unavailable / -19.60% |
LoseUNCY / S&P UNCY unavailable / 3.47% |
LoseUNCY / S&P UNCY unavailable / -14.75% |
| 2019-Q40/3 |
LoseUNCY / S&P UNCY unavailable / 9.07% |
LoseUNCY / S&P UNCY unavailable / 5.36% |
LoseUNCY / S&P UNCY unavailable / 2.99% |
| 2019-Q30/3 |
LoseUNCY / S&P UNCY unavailable / 1.70% |
LoseUNCY / S&P UNCY unavailable / 5.02% |
LoseUNCY / S&P UNCY unavailable / 0.21% |
| 2019-Q20/3 |
LoseUNCY / S&P UNCY unavailable / 4.30% |
LoseUNCY / S&P UNCY unavailable / 6.64% |
LoseUNCY / S&P UNCY unavailable / 8.65% |
| 2019-Q10/3 |
LoseUNCY / S&P UNCY unavailable / 13.65% |
LoseUNCY / S&P UNCY unavailable / 8.12% |
LoseUNCY / S&P UNCY unavailable / 14.29% |
| 2018-Q40/3 |
LoseUNCY / S&P UNCY unavailable / -13.52% |
LoseUNCY / S&P UNCY unavailable / 9.05% |
LoseUNCY / S&P UNCY unavailable / 18.23% |
| 2018-Q30/3 |
LoseUNCY / S&P UNCY unavailable / 7.71% |
LoseUNCY / S&P UNCY unavailable / 10.21% |
LoseUNCY / S&P UNCY unavailable / 19.06% |
| 2018-Q20/3 |
LoseUNCY / S&P UNCY unavailable / 3.43% |
LoseUNCY / S&P UNCY unavailable / 9.03% |
LoseUNCY / S&P UNCY unavailable / 14.46% |
| 2018-Q10/3 |
LoseUNCY / S&P UNCY unavailable / -0.76% |
LoseUNCY / S&P UNCY unavailable / 7.68% |
LoseUNCY / S&P UNCY unavailable / 12.46% |
| 2017-Q40/3 |
LoseUNCY / S&P UNCY unavailable / 6.64% |
LoseUNCY / S&P UNCY unavailable / 7.03% |
LoseUNCY / S&P UNCY unavailable / 13.82% |
| 2017-Q30/3 |
LoseUNCY / S&P UNCY unavailable / 4.48% |
LoseUNCY / S&P UNCY unavailable / 5.68% |
LoseUNCY / S&P UNCY unavailable / 17.57% |
| 2017-Q20/3 |
LoseUNCY / S&P UNCY unavailable / 3.09% |
LoseUNCY / S&P UNCY unavailable / 4.83% |
LoseUNCY / S&P UNCY unavailable / 17.74% |
| 2017-Q10/3 |
LoseUNCY / S&P UNCY unavailable / 6.07% |
LoseUNCY / S&P UNCY unavailable / 3.67% |
LoseUNCY / S&P UNCY unavailable / 13.32% |
| 2016-Q40/3 |
LoseUNCY / S&P UNCY unavailable / 3.82% |
LoseUNCY / S&P UNCY unavailable / 2.09% |
LoseUNCY / S&P UNCY unavailable / 7.05% |
| 2016-Q30/3 |
LoseUNCY / S&P UNCY unavailable / 3.85% |
LoseUNCY / S&P UNCY unavailable / 0.20% |
LoseUNCY / S&P UNCY unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | UNCY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 25.55% | 20.78% |
| Annualized return | 25.55% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | UNCY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -81.01% | 83.14% |
| Annualized return | -28.27% | 12.86% |
10Y · 2021-07-12 to 2026-08-28
| Metric | UNCY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -89.48% | 319.30% |
| Annualized return | -20.16% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |